Doctors and experts on a panel created by the National Institutes of Health are recommending against using hydroxychloroquine, an anti-malaria drug, with azithromycin, an antibiotic known as Z-Pak, in the treatment of COVID-19.
NIH Panel Opposes Hydroxychloroquine With Z-Pak to Treat COVID-19
Written by Zachary Steiber